Extended preoperative chemotherapy does not improve pathologic response and increases postoperative liver insufficiency after hepatic resection for colorectal liver metastases

Annals of Surgical Oncology

Volumn 17, Issue 11, 2010, Pages 2870-2876

  Kishi, Yoji ^a   Zorzi, Daria ^a   Contreras, Carlo M ^a   Maru, Dipen M ^a   Kopetz, Scott ^a   Ribero, Dario ^b   Motta, Manuela ^b   Ravarino, Nicoletta ^b   Risio, Mauro ^b   Curley, Steven A ^a   Abdalla, Eddie K ^a   Capussotti, Lorenzo ^b   Vauthey, Jean Nicolas ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b MAURIZIANO HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; FLUOROURACIL; FOLINIC ACID; OXALIPLATIN;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER SURGERY; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; INCIDENCE; LETHAL DOSE; LIVER FAILURE; LIVER INJURY; LIVER METASTASIS; LIVER RESECTION; LIVER SINUSOID; LIVER TOXICITY; MAJOR CLINICAL STUDY; MALE; METASTASIS; MORBIDITY; MULTIPLE CYCLE TREATMENT; MULTIVARIATE ANALYSIS; POSTOPERATIVE INFECTION; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; RADIOFREQUENCY ABLATION; TREATMENT DURATION; TREATMENT RESPONSE;

ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; COLORECTAL NEOPLASMS; DRUG ADMINISTRATION SCHEDULE; FEMALE; FLUOROURACIL; HEPATECTOMY; HEPATIC INSUFFICIENCY; HUMANS; LEUCOVORIN; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; ORGANOPLATINUM COMPOUNDS; PREOPERATIVE CARE; REMISSION INDUCTION;

EID: 78049457753     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-010-1166-1     Document Type: Article

References (20)

1. R Adam V Delvart G Pascal A Valeanu D Castaing D Azoulay, et al. 2004 Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy: a model to predict long-term survival Ann Surg 240 644 657 10.1097/01.sla.0000145964.08365.01 15383792 (Pubitemid 39602132)
2. B Nordlinger H Sorbye B Glimelius GJ Poston PM Schlag P Rougier, et al. 2008 Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial Lancet 371 1007 1016 10.1016/S0140- 6736(08)60455-9 18358928 (Pubitemid 351392040)
3. L Rubbia-Brandt E Giostra C Brezault A Roth A Andres V Audard, et al. 2007 Importance of histological tumor response assessment in predicting the outcome in patients with colorectal liver metastases treated with neoadjuvant chemotherapy followed by liver surgery Ann Oncol 18 299 304 10.1093/annonc/ mdl386 17060484 (Pubitemid 46323097)
4. R Adam DA Wicherts RJ de Haas T Aloia F Levi B Paule, et al. 2008 Complete pathologic response after preoperative chemotherapy for colorectal liver metastases: myth or reality? J Clin Oncol 26 1635 1641 10.1200/JCO.2007.13.7471 18375892
5. DG Blazer III Y Kishi DM Maru S Kopetz YS Chun MJ Overman, et al. 2008 Pathologic response to preoperative chemotherapy: a new outcome end point after resection of hepatic colorectal metastases J Clin Oncol 26 5344 5351 10.1200/JCO.2008.17.5299 18936472
6. D Ribero H Wang M Donadon D Zorzi MB Thomas C Eng, et al. 2007 Bevacizumab improves pathologic response and protects against hepatic injury in patients treated with oxaliplatin-based chemotherapy for colorectal liver metastases Cancer 110 2761 2767 10.1002/cncr.23099 17960603 (Pubitemid 350250347)
7. JN Vauthey TM Pawlik D Ribero TT Wu D Zorzi PM Hoff, et al. 2006 Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases J Clin Oncol 24 2065 2072 10.1200/JCO.2005.05.3074 16648507 (Pubitemid 46622116)
8. L Rubbia-Brandt V Audard P Sartoretti AD Roth C Brezault M Le Charpentier, et al. 2004 Severe hepatic sinusoidal obstruction associated with oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer Ann Oncol 15 460 466 10.1093/annonc/mdh095 14998849 (Pubitemid 38444550)
9. H Nakano E Oussoultzoglou E Rosso S Casnedi MP Chenard-Neu P Dufour, et al. 2008 Sinusoidal injury increases morbidity after major hepatectomy in patients with colorectal liver metastases receiving preoperative chemotherapy Ann Surg 247 118 124 10.1097/SLA.0b013e31815774de 18156931
10. M Karoui C Penna M Amin-Hashem E Mitry S Benoist B Franc, et al. 2006 Influence of preoperative chemotherapy on the risk of major hepatectomy for colorectal liver metastases Ann Surg 243 1 7 10.1097/01.sla.0000193603.26265.c3 16371728 (Pubitemid 43054046)
11. T Aloia M Sebagh M Plasse V Karam F Levi S Giacchetti, et al. 2006 Liver histology and surgical outcomes after preoperative chemotherapy with fluorouracil plus oxaliplatin in colorectal cancer liver metastases J Clin Oncol 24 4983 4990 10.1200/JCO.2006.05.8156 17075116 (Pubitemid 46631400)
12. D Dindo N Demartines PA Clavien 2004 Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey Ann Surg 240 205 213 10.1097/01.sla.0000133083.54934.ae 15273542 (Pubitemid 38963009)
13. JT Mullen D Ribero SK Reddy M Donadon D Zorzi S Gautam, et al. 2007 Hepatic insufficiency and mortality in 1, 059 noncirrhotic patients undergoing major hepatectomy J Am Coll Surg 204 854 862 10.1016/j.jamcollsurg.2006.12.032 17481498 (Pubitemid 46661186)
14. M Klinger S Eipeldauer S Hacker B Herberger D Tamandl M Dorfmeister, et al. 2009 Bevacizumab protects against sinusoidal obstruction syndrome and does not increase response rate in neoadjuvant XELOX/FOLFOX therapy of colorectal cancer liver metastases Eur J Surg Oncol 35 515 520 19200687
15. CJ Allegra G Yothers MJ O'Connell S Sharif LH Colangelo SH Lopa, et al. 2009 Initial safety report of NSABP C-08: a randomized phase III study of modified FOLFOX6 with or without bevacizumab for the adjuvant treatment of patients with stage II or III colon cancer J Clin Oncol 27 3385 3390 10.1200/JCO.2009.21.9220 19414665
16. S Kopetz JN Vauthey 2008 Perioperative chemotherapy for resectable hepatic metastases Lancet 371 963 965 10.1016/S0140-6736(08)60429-8 18358910 (Pubitemid 351389517)
17. JP Welch HS Tilney PP Tekkis TG John M Rees 2007 Safe liver resection following chemotherapy for colorectal metastases is a matter of timing Br J Cancer 96 1037 1042 10.1038/sj.bjc.6603670 (Pubitemid 46608314)
18. B Gruenberger D Tamandl J Schueller W Scheithauer C Zielinski F Herbst, et al. 2008 Bevacizumab, capecitabine, and oxaliplatin as neoadjuvant therapy for patients with potentially curable metastatic colorectal cancer J Clin Oncol 26 1830 1835 10.1200/JCO.2007.13.7679 18398148
19. SB Kesmodel LM Ellis E Lin GJ Chang EK Abdalla S Kopetz, et al. 2008 Preoperative bevacizumab does not significantly increase postoperative complication rates in patients undergoing hepatic surgery for colorectal cancer liver metastases J Clin Oncol 26 5254 5260 10.1200/JCO.2008.17.7857 18854565
20. A Brouquet S Benoist C Julie C Penna A Beauchet, et al. 2009 Risk factors for chemotherapy-associated liver injuries: a multivariate analysis of a group of 146 patients with colorectal metastases Surgery 145 362 371 10.1016/j.surg.2008.12.002 19303984